KRAS and pancreatic intraductal papillary-mucinous neoplasm: Recent data obtained from a mice IPMN model suggest that KRAS activation promotes the formation of the neoplasm [34], although in humans, there is no link between the presence of KRAS mutations and progression of IPMN [33,35].